Duncan J. Ewin
Leeds, ENG LS29JT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source.
Journal: JAC-antimicrobial resistance
Published: April 19, 2024
In vitro models to study Clostridioides difficile infection: current systems and future advances.
Journal: Current opinion in gastroenterology
Published: December 12, 2022
MiGut: A scalable in vitro platform for simulating the human gut microbiome-Development, validation and simulation of antibiotic-induced dysbiosis.
Journal: Microbial biotechnology
Published: October 11, 2022
A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: July 01, 2022
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota.
Journal: Frontiers in microbiology
Published: March 22, 2022
From the hospital toilet to the ward: A pilot study on microbe dispersal to multiple hospital surfaces following hand drying using a jet air dryer versus paper towels.
Journal: Infection control and hospital epidemiology
Published: March 17, 2021
The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection.
Journal: The Journal of antimicrobial chemotherapy
Published: March 15, 2021
The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model.
Journal: The Journal of hospital infection
Published: December 15, 2020
A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models.
Journal: Frontiers in microbiology
Published: July 01, 2020
Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut model.
Journal: The Journal of antimicrobial chemotherapy
Published: April 15, 2020
Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection.
Journal: NPJ biofilms and microbiomes
Published: February 28, 2020
Last Updated: 09/26/2026